ONCASPAR (PEGASPARGASE)
NCASPAR (pegaspargase) is indicated as a component of a multi-agent chemotherapeutic regimen for the first–line treatment of patients with acute lymphoblastic leukemia (ALL) and for the treatment of patients with ALL and hypersensitivity to native forms of L-asparaginase.
ONCASPAR (PEGASPARGASE)
Industry:
Medical Device
Founded:
1986-01-01
Website Url:
http://www.oncaspar.com
Status:
Active
Contact:
844-229-7575
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Tag Manager Amazon Amazon Virginia Region DigiCert SSL Pound Sterling Typekit Japanese Yen
Official Site Inspections
http://www.oncaspar.com Semrush global rank: 6.58 M Semrush visits lastest month: 954
- Host name: 20.232.9.129
- IP address: 20.232.9.129
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ONCASPAR (pegaspargase)"
ONCASPAR Ordering - ServierONE
Provider Support for the New ONCASPAR Ordering Process: Stay up to date with the latest information on the NEW Oncaspar Ordering Process here. Loading. ... Your ability to register as a new organization; Our IT Support is actively …See details»
Oncaspar - European Medicines Agency (EMA)
Oncaspar is normally given every 14 days by injection into a muscle or by infusion (drip) into a vein, with the dose depending on age and body surface area. Oncaspar can only be obtained …See details»
ONCASPAR (pegaspargase) - Crunchbase Company …
Organization. ONCASPAR (pegaspargase) Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Alternatives and possible competitors to ONCASPAR (pegaspargase) may include …See details»
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION …
Oncaspar may result in central nervous system toxicities. As such, patients should be monitored for signs of central nervous system dysfunctions, including but not limited to: convulsions, …See details»
Pegaspargase - Wikipedia
Pegaspargase, sold under the brand name Oncaspar, is a medication used in the treatment of acute lymphoblastic leukemia (ALL). [5] Often it is used together with anthracycline, vincristine, …See details»
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS - European …
Oncaspar is indicated as a component of antineoplastic combination therapy in acute lymphoblastic leukaemia (ALL) in paediatric patients from birth to 18 years, and adult patients. …See details»
Oncaspar (pegaspargase - European Medicines Agency
Oncaspar (pegaspargase) An overview of Oncaspar and why it is authorised in the EU . What is Oncaspar and what is it used for? Oncaspar is a cancer medicine used in adults and children …See details»
Oncaspar (pegaspargase) injection Label - Food and Drug …
Oncaspar ® safely and effectively. See full prescribing information for • 3,750 International Units/5 mL solution in a single-use vial. (3) Oncaspar ®. Oncaspar ® (pegaspargase) injection, for …See details»
FDA Approves Oncaspar for First-Line ALL - Cancer Network
Aug 1, 2006 Oncaspar was initially approved in February 1994 for the treatment of ALL patients unable to tolerate L-asparaginase because of allergic reactions. To support the new indication, …See details»
Patient Oncaspar Medical Financial Assistance - ServierONE
ONCASPAR may cause serious side effects including: Allergic reactions (Symptoms: hives and itching, a swollen tongue or throat, trouble breathing, dizziness, fainting) ... Your ability to …See details»
Oncaspar 750 U/ml powder for solution for injection/infusion
Oncaspar is to be administered intravenously or intramuscularly after reconstitution of the product. The powder must be reconstituted with 5.2 ml water for injections prior to administration (see …See details»
Oncaspar Advanced Patient Information - Drugs.com
Jan 12, 2024 Related/similar drugs. Blincyto, methotrexate, imatinib, doxorubicin, Sprycel, Gleevec, mercaptopurine. Precautions while using Oncaspar. It is very important that your …See details»
ONCASPAR Prescription & Dosage Information - MPR
ONCASPAR prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and ONCASPARside effects.See details»
Oncospar - Chemocare
What side effects may I notice from receiving this medication? Side effects that you should report to your care team as soon as possible: Allergic reactions or angioedema—skin rash, itching or …See details»
Frequently Asked Questions About Oncaspar® (Pegaspargase)
Jun 1, 2018 Oncaspar has been formulated to remain active in the body for a longer period of time than asparaginase. Oncaspar produces its anti-cancer effects in the same manner as …See details»
Oncaspar Uses, Side Effects & Warnings - Drugs.com
Jul 22, 2024 Oncaspar may harm an unborn baby. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 3 months after your last dose. Tell …See details»
Oncaspar: Uses, Taking, Side Effects, Warnings - Medicine.com
Feb 16, 2020 Before taking Oncaspar, tell your doctor: If you are allergic to Oncaspar; any part of this medicine; or any other drugs, foods, or substances. Tell your doctor about the allergy …See details»
Oncaspar (Pegaspargase) for Leukemia | MyLeukemiaTeam
Oncaspar may also be referred to by its drug name, pegaspargase. Oncaspar is the modified form of an enzyme called asparaginase. An enzyme is a molecule that accelerates a chemical …See details»
Oncaspar Dosage Guide - Drugs.com
Oct 7, 2024 Administer ONCASPAR in a healthcare setting with appropriate medical support and resuscitation equipment to manage hypersensitivity reactions, should they occur. …See details»